IRD
Opus Genetics, Inc.
4.50$
+1.1%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | +389.0% | – | – | – | – | – | -95.6% | +110.1% | +224.9% | -85.8% | +1.2% | -35.0% | +247.8% | +11.2% | +1.6% | -34.1% | +6.8% | +25.5% | -44.2% | -65.0% | – | |
| – | – | – | – | – | – | – | – | +0.8% | -33.7% | -10.3% | – | – | – | – | +469,700.0% | – | – | – | – | -99.8% | +46,223.1% | -99.8% | +0.0% | +0.0% | – | – | |
| – | – | – | – | – | – | +389.0% | -1,068.5% | – | – | – | – | -109.7% | – | +224.9% | -125.2% | – | -35.0% | +247.8% | -189.9% | – | -171.9% | – | +25.5% | -44.5% | -64.8% | – | |
| – | +226.1% | +94.5% | +213.6% | -19.7% | +10.0% | -18.4% | +51.5% | +0.8% | -33.7% | -10.3% | +26.5% | +56.0% | -15.6% | -26.0% | +9.9% | +23.6% | +28.2% | +47.6% | -21.7% | +13.1% | -24.3% | +6.4% | +62.7% | +1.4% | +6.0% | – | |
| – | +40.9% | +2.5% | +131.9% | +30.1% | +100.0% | -53.2% | -11.3% | +22.8% | +2.3% | -4.1% | +20.6% | +11.2% | +89.9% | -52.6% | +59.6% | +42.4% | -28.2% | -13.7% | +152.1% | -13.0% | -9.1% | -13.6% | -1.8% | +21.3% | +1.6% | – | |
| – | -53.9% | +54.4% | +619.9% | -87.8% | +324.7% | -34.8% | -70.0% | +22.8% | +2.3% | -4.1% | +231.2% | -59.5% | +296.6% | -38.8% | -56.4% | +288.9% | +0.2% | +25.8% | +190.9% | -58.6% | -59.7% | +97.5% | +34.5% | +7.8% | +4.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | -117.9% | – | – | -185.0% | – | – | – | – | – | – | – | – | – | – | – | |
| – | +24.4% | -74.0% | +2,930.7% | – | – | – | – | +150.0% | -20.0% | – | – | – | – | – | -100.0% | – | – | – | – | – | -97.4% | +94.3% | +1,955.9% | -53.4% | -18.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | -116.9% | – | – | -186.0% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -114.3% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | -117.1% | – | – | -186.2% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | -116.9% | – | – | -169.4% | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.